Average Co-Inventor Count = 4.12
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Rhizen Pharmaceuticals Sa (14 from 51 patents)
2. Rhizen Pharmaceuticals Ag (2 from 5 patents)
3. Incozen Therapeutics Pvt. Ltd. (1 from 7 patents)
16 patents:
1. 11466006 - Dual selective PI3 delta and gamma kinase inhibitors
2. 11352359 - PI3K protein kinase inhibitors
3. 11066402 - 3,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases
4. 11020399 - Intermediates useful in the synthesis of compounds as modulators of protein kinases
5. 10851107 - Dual selective P13 delta and gamma kinase inhibitors
6. 10611759 - Glutaminase inhibitors
7. 10322130 - Substituted chromenones as modulators of protein kinases
8. 10220035 - Compounds as modulators of protein kinases
9. 10179786 - Selective dual inhibitors of PI3 delta and gamma protein kinases
10. 9815831 - 3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases
11. 9790224 - Dual selective PI3 delta and gamma kinase inhibitors
12. 9783533 - Glutaminase inhibitors
13. 9775841 - Compounds as modulators of protein kinases
14. 9758474 - Immunomodulator and anti-inflammatory compounds
15. 9708329 - Selective dual inhibitors of PI3 delta and gamma protein kinases